Quipt Home Medical (NASDAQ:QIPT - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.09), Zacks reports. Quipt Home Medical had a negative net margin of 2.90% and a negative return on equity of 6.70%. The company had revenue of $57.40 million during the quarter, compared to the consensus estimate of $88.29 million.
Quipt Home Medical Stock Down 3.2%
NASDAQ:QIPT traded down $0.05 during mid-day trading on Thursday, hitting $1.50. 116,412 shares of the company's stock were exchanged, compared to its average volume of 196,325. Quipt Home Medical has a one year low of $1.46 and a one year high of $4.17. The company has a market cap of $64.64 million, a PE ratio of -8.86 and a beta of 0.65. The business has a fifty day moving average price of $2.17 and a 200 day moving average price of $2.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.22 and a quick ratio of 0.87.
Analyst Ratings Changes
A number of research analysts recently commented on the stock. Benchmark reiterated a "buy" rating and issued a $4.00 price target (down previously from $6.00) on shares of Quipt Home Medical in a research note on Wednesday. Canaccord Genuity Group reaffirmed a "hold" rating and issued a $1.70 price objective (down from $4.00) on shares of Quipt Home Medical in a research note on Tuesday. One research analyst has rated the stock with a sell rating, one has issued a hold rating, two have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Quipt Home Medical has a consensus rating of "Moderate Buy" and a consensus target price of $4.43.
Get Our Latest Stock Analysis on Quipt Home Medical
Quipt Home Medical Company Profile
(
Get Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Stories

Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.